Rani Therapeutics Holdings, Inc. Class A Common Stock (RANI) is a publicly traded Healthcare sector company. As of August 24, 2026, RANI trades at $0.88 with a market cap of $98.23M and a P/E ratio of -1.95. RANI moved +2.96% today. Year to date, RANI is -35.29%; over the trailing twelve months it is +60.41%. Its 52-week range spans $0.39 to $3.87. Analyst consensus is strong buy with an average price target of $7.50. Rallies surfaces RANI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rani Therapeutics Holdings, Inc. Class A Common Stock (RANI) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. RANI moved +2.96% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $0.88 |
| Market Cap | $98.23M |
| P/E Ratio | -1.95 |
| EPS | $-0.45 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.87 |
| 52-Week Low | $0.39 |
| Volume | 690.90K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.63M |
| Net Income | $-40.95M |
| Gross Margin | 0.00% |
4 analysts cover RANI: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $7.50.